Patients With Advanced Solid Tumors Who Discontinued Treatment Due to irAE
1 clinical trials · Condition
◉ Watch Patients With Advanced Solid Tumors Who Discontinued Treatment Due to irAE
| Record | Firm | Date |
|---|---|---|
| Ivarmacitinib in Advanced Solid Tumors: A Prospective, Two-Cohort, Two-Phase Exploratory Study in Patients Discontinued Due to Immune Intolerance (NCT07313202) | Fujian Cancer Hospital | 2025-12-10 |
Track Patients With Advanced Solid Tumors Who Discontinued Treatment Due to irAE automatically
Every clearance here is in the API, with alerts when new ones post.